PHARMACOLOGY AND THERAPEUTIC CONSIDERATIONS OF AMLODIPINE, A NEW 1,4-DIHYDROPYRIDINE CALCIUM-ANTAGONIST - GENERAL DISCUSSION

被引:0
|
作者
VANZWIETEN, PA
LUCCHESI, BR
CATAPANO, AL
VANHOUTTE
VANBREEMEN
MILLARD, RW
VANHOUTTE
GODFRAIND, T
EPSTEIN, M
BLACKBURN
SCHWARTZ, A
NAYLER, WG
BURGES, RA
MARSHALL
机构
[1] UNIV AMSTERDAM, ACAD MED CTR, DEPT CARDIOL, 1105 AZ AMSTERDAM, NETHERLANDS
[2] UNIV MICHIGAN, SCH MED, DEPT PHARMACOL, ANN ARBOR, MI 48109 USA
[3] UNIV MILAN, INST PHARMACOL SCI, I-20133 MILAN, ITALY
[4] UNIV CINCINNATI, COLL MED, DEPT PHARMACOL & CELL BIOPHYS, CINCINNATI, OH 45267 USA
[5] CATHOLIC UNIV LOUVAIN, PHARMACODYNAM GEN & PHARMACOL LAB, B-1200 BRUSSELS, BELGIUM
[6] VET ADM MED CTR, NEPHROL SECT, MIAMI, FL 33125 USA
[7] UNIV CINCINNATI, COLL MED, DEPT RADIOL, CINCINNATI, OH 45267 USA
[8] UNIV MELBOURNE, AUSTIN HOSP, DEPT MED, HEIDELBERG, VIC 3084, AUSTRALIA
[9] PFIZER LTD, DEPT DISCOVERY BIOL, SANDWICH CT13 9NJ, KENT, ENGLAND
来源
AMERICAN JOURNAL OF CARDIOLOGY | 1989年 / 64卷 / 17期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:I135 / I137
页数:3
相关论文
共 50 条
  • [41] Mitochondria may be the intracellular target for cerebrocrast, a non-calcium antagonist 1,4-dihydropyridine compound
    Klusa, V. Z.
    Fernandes, M. A. S.
    Klimaviciusa, L.
    Duburs, G.
    Kaasik, A.
    Kalda, A.
    Zharkovsky, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 107 - 107
  • [42] Synthesis and evaluation of calcium channel antagonist activity of some new imidazolyl 1,4-dihydropyridine analogues containing carbamoyl substitute
    Javidnia, Katayoun
    Miri, Ramin
    Edraki, Najme
    Khoshneviszadeh, Mehdi
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 130 - 130
  • [43] Synthesis and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing lipophilic 4-imidazolyl substituents
    Navidpour, L
    Miri, R
    Shafiee, A
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2004, 54 (09): : 499 - 504
  • [44] MOLECULAR-LEVEL MODEL FOR THE AGONIST ANTAGONIST SELECTIVITY OF THE 1,4-DIHYDROPYRIDINE CALCIUM-CHANNEL RECEPTOR
    LANGS, DA
    KWON, YW
    STRONG, PD
    TRIGGLE, DJ
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1991, 5 (02) : 95 - 106
  • [45] STEREOSELECTIVE DISPOSITION OF NILVADIPINE, A NEW DIHYDROPYRIDINE CALCIUM-ANTAGONIST, IN THE RAT AND DOG
    TOKUMA, Y
    FUJIWARA, T
    NIWA, T
    HASHIMOTO, T
    NOGUCHI, H
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1989, 63 (02): : 249 - 262
  • [46] Mechanochemical enzymatic synthesis of 1,4-dihydropyridine calcium antagonists and derivatives
    Jiang, Ling
    Ye, Li-dan
    Gu, Jia-li
    Su, Wei-ke
    Ye, Wen-ting
    JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, 2019, 94 (08) : 2555 - 2560
  • [47] Studies on condensed 1,4-dihydropyridine derivatives and their calcium modulatory activities
    Aydin, F.
    Safak, C.
    Simsek, R.
    Erol, K.
    Ulgen, M.
    Linden, A.
    PHARMAZIE, 2006, 61 (08): : 655 - 659
  • [48] Synthesis and calcium channel antagonist activity of 1,4-dihydropyridine derivatives containing 4-nitroimidazolyl substituents
    Shafiee, A
    Rastkary, N
    Jorjani, M
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2002, 52 (07): : 537 - 542
  • [49] EFFECTS OF AMLODIPINE, A LONG-ACTING DIHYDROPYRIDINE CALCIUM-ANTAGONIST IN AGING HYPERTENSION - PHARMACODYNAMICS IN RELATION TO DISPOSITION
    ABERNETHY, DR
    GUTKOWSKA, J
    WINTERBOTTOM, LM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (01) : 76 - 86
  • [50] MODULATION OF CALCIUM-CHANNEL FUNCTION WITH THE 1,4-DIHYDROPYRIDINE STRUCTURE
    SCHRAMM, M
    TOWART, R
    JOURNAL OF PHYSIOLOGY-LONDON, 1984, 349 (APR): : P53 - P53